首页> 外文会议>International Congress on Coronary Artery Disease >Inhibition of Renin Angiotensin Aldosterone System,and Insulin-Like Growth Factor-1 Axis and Physical Performance
【24h】

Inhibition of Renin Angiotensin Aldosterone System,and Insulin-Like Growth Factor-1 Axis and Physical Performance

机译:抑制肾素血管紧张素醛固酮体系,胰岛素样生长因子-1轴和物理性能

获取原文

摘要

Observational studies have shown that the use of angiotensin-converting enzyme (ACE) inhibitors (ACEIs) is associated with the maintenance of higher muscle strength and physical performance in older persons free of chronic heart failure. There is evidence of a direct role exerted by ACE-inhibitor treatment on parameters of physical performance, but the exact mechanism underlying the effects of ACEIs remains poorly understood. Since ACEIs block the production of Angiotensin II, which is a potent inhibitor of insulin-like growth factor-1 (IGF-1), it is conceivable that there is a relationship between ACEIs administration and serum IGF-1 levels. Decline of IGF-1 with age is also associated with poor muscle mass and strength.The link between ACE inhibitors or other medications inhibiting renin angiotensin aldosterone system, physical performance and IGF-1 will be analyzed in this review.
机译:观察性研究表明,使用血管紧张素转换酶(ACE)抑制剂(ACEIS)的使用与维持更高的肌肉力量和在较老年人没有慢性心力衰竭的人身上的身体表现有关。有证据表明ACE抑制剂治疗对物理性能参数的直接作用,但aceis效应的确切机制仍然尚不清楚。由于Aceis阻断了血管紧张素II的产生,这是胰岛素样生长因子-1(IGF-1)的有效抑制剂,可以想到aceis施用和血清IGF-1水平之间存在关系。随着年龄的增长,IGF-1的衰退也与肌肉质量和强度差有关。在本综述中,ACE抑制剂或抑制肾素血管紧张素醛酮系统,物理性能和IGF-1之间的联系将进行分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号